Table of Contents Author Guidelines Submit a Manuscript
Journal of Ophthalmology
Volume 2019, Article ID 1691064, 7 pages
https://doi.org/10.1155/2019/1691064
Research Article

Prediction of Causative Genes in Inherited Retinal Disorders from Spectral-Domain Optical Coherence Tomography Utilizing Deep Learning Techniques

1Laboratory of Visual Physiology, Division of Vision Research, National Institute of Sensory Organs, National Hospital Organization Tokyo Medical Center, Tokyo 152-8902, Japan
2Graduate School of Health Management, Keio University, Tokyo 160-0016, Japan
3UCL Institute of Ophthalmology, London EC1V 9EL, UK
4Moorfields Eye Hospital, London EC1V 2PD, UK
5Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100006, China
6Department of Ophthalmology, Keio University of Medicine, Tokyo 160-0016, Japan
7Division of Molecular and Cellular Biology, National Institute of Sensory Organs, National Tokyo Medical Center, Tokyo 152-8902, Japan
8Department of Health Policy and Management, School of Medicine, Keio University, Tokyo 160-8582, Japan

Correspondence should be addressed to Kaoru Fujinami; ku.ca.lcu@imanijuf.k

Received 3 December 2018; Accepted 11 March 2019; Published 9 April 2019

Academic Editor: Lawrence S. Morse

Copyright © 2019 Yu Fujinami-Yokokawa et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. Kumaran, M. E. Pennesi, P. Yang et al., “Leber congenital amaurosis/early-onset severe retinal dystrophy overview,” in GeneReviews((R)), M. P. Adam et al., Ed., Seattle, WA, USA, 2018. View at Google Scholar
  2. N. Kumaran, A. T. Moore, R. G. Weleber, and M. Michaelides, “Leber congenital amaurosis/early-onset severe retinal dystrophy: clinical features, molecular genetics and therapeutic interventions,” British Journal of Ophthalmology, vol. 101, no. 9, pp. 1147–1154, 2017. View at Publisher · View at Google Scholar · View at Scopus
  3. N. Hirji, J. Aboshiha, M. Georgiou, J. Bainbridge, and M. Michaelides, “Achromatopsia: clinical features, molecular genetics, animal models and therapeutic options,” Ophthalmic Genetics, vol. 39, no. 2, pp. 149–157, 2018. View at Publisher · View at Google Scholar · View at Scopus
  4. L. Sheck, W. I. L. Davies, P. Moradi et al., “Leber congenital amaurosis associated with mutations in CEP290 , clinical phenotype, and natural history in preparation for trials of novel therapies,” Ophthalmology, vol. 125, no. 6, pp. 894–903, 2018. View at Publisher · View at Google Scholar · View at Scopus
  5. J. J. L. Tee, A. J. Smith, A. J. Hardcastle, and M. Michaelides, “RPGR-associated retinopathy: clinical features, molecular genetics, animal models and therapeutic options,” British Journal of Ophthalmology, vol. 100, no. 8, pp. 1022–1027, 2016. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Smith, D. Ward, M. Michaelides, A. T. Moore, and S. Simpson, “New and emerging technologies for the treatment of inherited retinal diseases: a horizon scanning review,” Eye, vol. 29, no. 9, pp. 1131–1140, 2015. View at Publisher · View at Google Scholar · View at Scopus
  7. H. P. N. Scholl, R. W. Strauss, M. S. Singh et al., “Emerging therapies for inherited retinal degeneration,” Science Translational Medicine, vol. 8, no. 368, p. 368rv6, 2016. View at Publisher · View at Google Scholar · View at Scopus
  8. K. Fujinami, K. Tsunoda, G. Hanazono et al., “Fundus autofluorescence in autosomal dominant occult macular dystrophy,” Archives of Ophthalmology, vol. 129, no. 5, pp. 597–602, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. K. Fujinami, N. Lois, A. E. Davidson et al., “A longitudinal study of stargardt disease: clinical and electrophysiologic assessment, progression, and genotype correlations,” American Journal of Ophthalmology, vol. 155, no. 6, pp. 1075–1088, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. K. Fujinami, J. Zernant, R. K. Chana et al., “Clinical and molecular characteristics of childhood-onset Stargardt disease,” Ophthalmology, vol. 122, no. 2, pp. 326–334, 2015. View at Publisher · View at Google Scholar · View at Scopus
  11. K. Fujinami, S. Kameya, S. Kikuchi et al., “NovelRP1L1Variants and genotype-photoreceptor microstructural phenotype Associations in cohort of Japanese patients with occult macular dystrophy,” Investigative Opthalmology and Visual Science, vol. 57, no. 11, pp. 4837–46, 2016. View at Publisher · View at Google Scholar · View at Scopus
  12. K. Fujinami, N. Lois, R. Mukherjee et al., “A longitudinal study of Stargardt disease: quantitative assessment of fundus autofluorescence, progression, and genotype correlations,” Investigative Opthalmology and Visual Science, vol. 54, no. 13, pp. 8181–90, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. X. Kong, R. W Strauss, M Michaelides et al., “Visual acuity loss and associated risk factors in the retrospective progression of stargardt disease study (ProgStar report No. 2),” Ophthalmology, vol. 123, no. 9, pp. 1887–97, 2016. View at Publisher · View at Google Scholar · View at Scopus
  14. R. W. Strauss, A. Ho, B. Muñoz et al., “The natural history of the progression of atrophy secondary to stargardt disease (ProgStar) studies,” Ophthalmology, vol. 123, no. 4, pp. 817–828, 2016. View at Publisher · View at Google Scholar · View at Scopus
  15. K. Fujinami, P. I. Sergouniotis, A. E. Davidson et al., “The clinical effect of homozygous ABCA4 alleles in 18 patients,” Ophthalmology, vol. 120, no. 11, pp. 2324–2331, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. K. Fujinami, P. I. Sergouniotis, A. E. Davidson et al., “Clinical and molecular analysis of Stargardt disease with preserved foveal structure and function,” American Journal of Ophthalmology, vol. 156, no. 3, pp. 487–501, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. D. Zobor, G. Zobor, S. Hipp et al., “Phenotype variations caused by mutations in the RP1L1 gene in a large mainly German cohort,” Investigative Opthalmology and Visual Science, vol. 59, no. 7, pp. 3041–3052, 2018. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Kikuchi, S. Kameya, K. Gocho et al., “Cone dystrophy in patient with homozygous RP1L1 mutation,” BioMed Research International, vol. 2015, p. 545243, 2015. View at Publisher · View at Google Scholar · View at Scopus
  19. A. E. Davidson, P. I. Sergouniotis, D. S. Mackay et al., “RP1L1Variants are associated with a spectrum of inherited retinal diseases including retinitis pigmentosa and occult macular dystrophy,” Human Mutation, vol. 34, no. 3, pp. 506–514, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. S. J. Ahn, J. Ahn, K. H. Park, and S. J. Woo, “Multimodal imaging of occult macular dystrophy,” JAMA Ophthalmology, vol. 131, no. 7, pp. 880–90, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. S. J. Ahn, S. I. Cho, J. Ahn, S. S. Park, K. H. Park, and S. J. Woo, “Clinical and genetic characteristics of Korean occult macular dystrophy patients,” Investigative Opthalmology & Visual Science, vol. 54, no. 7, pp. 4856–63, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. S. J. Park, S. J. Woo, K. H. Park, J.-M. Hwang, and H. Chung, “Morphologic photoreceptor abnormality in occult macular dystrophy on spectral-domain optical coherence tomography,” Investigative Opthalmology and Visual Science, vol. 51, no. 7, pp. 3673–9, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. J. De Fauw, J. R. Ledsam, B. Romera-Paredes et al., “Clinically applicable deep learning for diagnosis and referral in retinal disease,” Nature Medicine, vol. 24, no. 9, pp. 1342–1350, 2018. View at Publisher · View at Google Scholar · View at Scopus
  24. N. Ramachandran, S. C. Hong, M. J. Sime, and G. A. Wilson, “Diabetic retinopathy screening using deep neural network,” Clinical & Experimental Ophthalmology, vol. 46, no. 4, pp. 412–416, 2018. View at Publisher · View at Google Scholar · View at Scopus
  25. U. Schmidt-Erfurth, A. Sadeghipour, B. S. Gerendas et al., “Artificial intelligence in retina,” Progress in Retinal and Eye Research, vol. 67, pp. 1–29, 2018. View at Publisher · View at Google Scholar · View at Scopus
  26. D. S. W. Ting, L. R. Pasquale, L. Peng et al., “Artificial intelligence and deep learning in ophthalmology,” British Journal of Ophthalmology, vol. 103, no. 2, pp. 167–175, 2019. View at Publisher · View at Google Scholar
  27. T. K. Redd, J. P Campbell, J. M Brown et al., “Evaluation of a deep learning image assessment system for detecting severe retinopathy of prematurity,” British Journal of Ophthalmology, 2018. View at Publisher · View at Google Scholar
  28. M. Treder, J. L. Lauermann, and N. Eter, “Deep learning-based detection and classification of geographic atrophy using a deep convolutional neural network classifier,” Graefe’s Archive for Clinical and Experimental Ophthalmology, vol. 256, no. 11, pp. 2053–2060, 2018. View at Publisher · View at Google Scholar · View at Scopus
  29. C. H. Stevenson, S. C. Hong, and K. C. Ogbuehi, “Development of an artificial intelligence system to classify pathology and clinical features on retinal fundus images,” Clinical and Experimental Ophthalmology, 2018. View at Publisher · View at Google Scholar